Cash & equivalents increased 35.5%
Cash & equivalents changed +35.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +35.5% from the comparable as-filed period.
Net income changed +408.8% from the comparable as-filed period.
Operating income changed +401.3% from the comparable as-filed period.
Operating margin changed +1611 basis points from the comparable as-filed period.
Stock-based compensation changed -40.0% from the comparable as-filed period.
Debt changed +6.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed -6.6% from the comparable as-filed period.
Revenue changed -2.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.